Transfusion independence and cytogenetic response in myelodysplastic syndromes. What this means for the patient

Published: June 10, 2009
Abstract Views: 175
PDF: 515
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Myelodysplastic syndromes (MDS) constitute a spectrum of hae matopoietic stem cell malignancies characterized by ineffective haematopoiesis, peripheral cytopenia, and increased risk of acute myeloid leukaemia (AML). Refractory anaemia is the presenting feature in approximately two-thirds of patients, with anaemia usually developing in the remainder as the disease progresses.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

List, A. F. (2009). Transfusion independence and cytogenetic response in myelodysplastic syndromes. What this means for the patient. Hematology Meeting Reports (formerly Haematologica Reports), 2(14). https://doi.org/10.4081/hmr.v2i14.509